RanizuRel 0.5 mg Ranibizumab Injection

RanizuRel contains ranibizumab 2.3 mg/0.23 ml (0.5 mg dose) as a sterile, preservative‑free solution for single‑use intravitreal injection, used by ophthalmologists to treat neovascular (wet) AMD, diabetic macular edema, macular edema following retinal vein occlusion, and other VEGF‑mediated retinal disorders.

RanizuRel – Ranibizumab Injection 0.5 mg (2.3 mg/0.23 ml per vial)
Manufacturer: Reliance Life Sciences

COMBI KIT CONTENTS:

• One vial of Ranibizumab solution

• One syringe

• Two needles (filter + injection)

• One alcohol swab

DOSAGE:

As directed by the Ophthalmologist.

TORAGE:

• Store at 2°C – 8°C (Refrigerated)

• Do not freeze